SCHEMBL22015517

SCHEMBL22015517

CNc1cnn2c1OCC(C)(C)C2

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.35
LRRK2 Q5S007 1/20 0.34
KAT2B Q92831 1/20 0.30
BRD9 Q9H8M2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22012262 0.79
SCHEMBL23750853 0.78
Hydrochloric Acid SCHEMBL26121505 0.77 GRM5 (0.31)
SCHEMBL24871787 0.75
SCHEMBL23762604 0.75
SCHEMBL25033662 0.75 GRM5 (0.30)
SCHEMBL24132252 0.74
SCHEMBL20828397 0.74 ALOX5 (0.36) LRRK2KAT2BBRD9
SCHEMBL20400508 0.72
SCHEMBL20399915 0.72 NLRP3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed